Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.

Learn More


Luminex® Blog

At the Serum Institute of India, Vaccine Development Requires Multiplex Assays

Bonus: Pro tips for xMAP® assay developers

Since 1967, the Serum Institute of India has launched more than 20 vaccines, with five more vaccines in the pipeline specifically designed to target infectious diseases that are prevalent in developing countries. Impressively, the institute has produced more than 1.3 billion high-quality, low-cost vaccine doses.

Continue Reading >

xMAP® Technology Overview

Luminex xMAP® Technology Overview


xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter

Every 2 minutes, someone loses their life to #sepsis. Do you know what it is and how to stop it? Learn more during…
h J R
Did you know that #sepsis is the 3rd leading cause of death in the U.S? Learn more in our blog.…
h J R
Want to learn more about biomarker selection strategies for budget friendly methods of assay development? Check out…
h J R

Latest News

September 11
Luminex Corporation Declares Third Quarter Cash Dividend

September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference

August 6
Luminex Corporation Reports Second Quarter 2018 Financial Results

July 13
Luminex Corporation Second Quarter Earnings Release Scheduled for August 6, 2018

June 13
Luminex Initiates Clinical Trials for VERIGENE® II Gastrointestinal Assay


October 3-7
San Francisco, California

AMP Annual Meeting
November 1-3
San Antonio, Texas

xMAP® Connect Amsterdam
November 6-7
Amsterdam, Netherlands